Haralabos Kalofonos

Haralabos Kalofonos

University of Patras - Patras / Greece
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1842663
Πανεπιστήμιο Πατρών
person_outline Haralabos Kalofonos's MOST POPULAR ARTICLES
1-) Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancerSJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ...New England Journal of Medicine 377 (20), 1919-1929, 201730842017
2-) First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancerL Horn, AS Mansfield, A Szczęsna, L Havel, M Krzakowski, MJ Hochmair, ...New England Journal of Medicine 379 (23), 2220-2229, 201823992018
3-) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLCSJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ...New England Journal of Medicine 379 (24), 2342-2350, 201823802018
4-) Avelumab maintenance therapy for advanced or metastatic urothelial carcinomaT Powles, SH Park, E Voog, C Caserta, BP Valderrama, H Gurney, ...New England Journal of Medicine 383 (13), 1218-1230, 202012222020
5-) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialM Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...The lancet oncology 18 (12), 1688-1700, 20176912017